Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer

Xiao He, Xianjie Cheng, Zhun Zhang, Lanhui Chen, Changjun Xie, Mengjie Tang

Open source

DOI
10.3389/fphar.2025.1533571
Published
2025-01-22
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1533571,
  title = {Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer},
  author = {Xiao He and Xianjie Cheng and Zhun Zhang and Lanhui Chen and Changjun Xie and Mengjie Tang},
  year = {2025},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2025.1533571},
  url = {https://doi.org/10.3389/fphar.2025.1533571}
}

RIS

TY  - JOUR
TI  - Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer
AU  - Xiao He
AU  - Xianjie Cheng
AU  - Zhun Zhang
AU  - Lanhui Chen
AU  - Changjun Xie
AU  - Mengjie Tang
PY  - 2025
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2025.1533571
UR  - https://doi.org/10.3389/fphar.2025.1533571
ER  - 

APA

He, X., Cheng, X., Zhang, Z., Chen, L., Xie, C., & Tang, M. (2025). Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1533571

Source records